[1] Madrigal-Santillán E, Madrigal-Bujaidar E, ?lvarez-González I, et al. Review of natural products with hepatoprotective effects. World J Gastroenterol, 2014, 20: 14787.
[2] 王志明, 董银英, 周乐源, 等. 大鼠肝脏非实质细胞的分离与培养, 鉴定. 中华实验外科杂志, 2014, 31: 985-987.
[3] Talalay P, Dinkova-Kostova AT, Holtzclaw WD. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul, 2003, 43: 121-134.
[4] 王贵阳, 李可为. 氧化应激在胆汁淤积性肝损伤中的作用及抗氧化治疗研究进展. 中国现代普通外科进展, 2014, 17: 38-41.
[5] Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med, 2012, 52: 59-69.
[6] Aldaba-Muruato LR, Moreno MG, Shibayama M, et al. Protective effects of allopurinol against acute liver damage and cirrhosis induced by carbon tetrachloride: modulation of NF-κB, cytokine production and oxidative stress. Biochim Biophys Acta, 2012, 1820: 65-75.
[7] Ivanov AV, Smirnova OA, Ivanova ON, et al. Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells. PLoS One, 2011, 6: e24957.
[8] Zhu R, Wang Y, Zhang L, et al. Oxidative stress and liver disease. Hepatol Res, 2012, 42: 741-749.
[9] The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol, 2013, 1: 45-49.
[10] Gao B, Doan A, Hybertson BM. The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders. Clin Pharmacol, 2014, 6: 19.
[11] Sato K, Yama K, Murao Y, et al. Epalrestat increases intracellular glutathione levels in Schwann cells through transcription regulation. Redox Biol, 2014, 2: 15-21.
[12] Ma L, Liu X, Zhao Y, et al. Ginkgolide B reduces LOX-1 expression by inhibiting Akt phosphorylation and increasing Sirt1 expression in oxidized LDL-stimulated human umbilical vein endothelial cells. PLoS One, 2013, 8: e74769.
[13] Liu Z, Xiang Y, Sun G. The KCTD family of proteins: structure, function, disease relevance. Cell Biosci, 2013, 3: 45.
[14] Kobayashi E, Suzuki T, Yamamoto M. Roles nrf2 plays in myeloid cells and related disorders. Oxid Med Cell Longev, 2013, 2013.
[15] Saldanha JF, Leal VO, Stenvinkel P, et al. Resveratrol: why is it a promising therapy for chronic kidney disease patients?. Oxid Med Cell Longev, 2013, 2013.
[16] Mercado N, Kizawa Y, Ueda K, et al. Activation of transcription factor Nrf2 signalling by the sphingosine kinase inhibitor SKI-II is mediated by the formation of Keap1 dimers. PLoS One, 2014, 9: e88168.
[17] Tao S, Justiniano R, Zhang D D, et al. The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV. Redox Biol, 2013, 1: 532-541.
[18] Waris G, Siddiqui A. Regulatory mechanisms of viral hepatitis B and C.J Biosci, 2003, 28: 311-322.
[19] Schaedler S, Krause J, Himmelsbach K, et al. Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2. J Biol Chem, 2010, 285: 41074-41086.
[20] 李婷婷,殷森,徐玉霞,等. 普通棉耳绒猴MHC-I类基因A和B基因座多态性分析. 中国输血杂志,2012,S1:159.
[21] Seren Ö, RLER GE, Özlem GÜLBAHAR ÖB. Serum levels of advanced oxidation protein products, malonyldialdehyde, and total radical trapping antioxidant parameter in patients with chronic hepatitis C. Turk J Gastroenterol, 2011, 22: 47-53.
[22] Lee JC, Tseng CK, Young KC, et al. Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells. Br J Pharmacol, 2014, 171: 237-252.
[23] Chen S, Zou L, Li L, et al. The protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2. PloS one, 2013, 8: e53662.
[24] Abd El Motteleb DM, Ibrahim IAAE, Elshazly SM. Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1). Toxicol Appl Pharmacol, 2017, 335: 64-71.
[25] El-Serag H B, Rudolph K L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 2007, 132: 2557-2576.
[26] Kitamura Y, Umemura T, Kanki K, et al. Increased susceptibility to hepatocarcinogenicity of Nrf2-deficient mice exposed to 2-amino-3-methylimidazo[4,5-f] quinoline. Cancer Sci, 2007, 98: 19-24
[27] Bishayee A, Bhatia D, Thoppil RJ, et al. Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis, 2011, 32: 888-896.
[28] Kansanen E, Kuosmanen SM, Leinonen H, et al. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol, 2013, 1: 45-49. |
